NCT00444574View on ClinicalTrials.gov

Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate Transdermal System

The primary objective of this study was to evaluate, under controlled conditions, the safety and efficacy of MTS compared to placebo with reference to CONCERTA

DRUG

Placebo

The primary objective of this study was to evaluate, under controlled conditions, the safety and efficacy of MTS compared to placebo with reference to CONCERTA

DRUG

Concerta

The primary objective of this study was to evaluate, under controlled conditions, the safety and efficacy of MTS compared to placebo with reference to CONCERTA

Sponsors

Lead Sponsor

Noven Therapeutics
All Listed Sponsors
lead

Noven Therapeutics

INDUSTRY